Aug. 10 IPO brief: FOIL targets Aug. 12 listing, but no retail window is verified
Londian Wason's copper-foil IPO is the main U.S. watch this week, with institutional indications above the midpoint deal but no verified mainstream-broker subscription path; Hong Kong has no active public offer today.
Monday, August 10, 2026 is a regular NYSE trading day. The short version: no mainstream U.S. IPO allocation is publicly verified as open today, while Londian Wason New Energy Tech is the main deal to watch before its expected August 12 NYSE debut. Hong Kong has no active public subscription in the current timetable. 1
Today's spotlight: Londian Wason New Energy Tech (FOIL)
Status: Watch only. The proposed IPO is 3.57 million ADSs at $20-$22, with an expected August 12 NYSE listing. Each ADS represents five ordinary shares. At the midpoint, the deal would raise about $75 million and imply a market value near $1.6 billion. 23
Business in one sentence: Londian Wason makes electrolytic copper foil used in lithium-ion batteries, circuit boards, energy storage systems and electric vehicles. Its customers include CATL, BYD, LG Energy Solution, Samsung SDI and Panasonic. 2
Why retail investors care: The company says it was the world's largest lithium-ion battery copper-foil supplier by 2025 sales volume, with a 7.6% global share and about 111,985 metric tons supplied that year. That gives FOIL a clear battery-supply-chain angle rather than a vague clean-energy label. 2
Demand signal: Investors led by Harvest Fund Management indicated interest in about $87 million of ADSs, or roughly 115% of the offering at the midpoint. That is an indication, not a completed purchase and not a guarantee of a strong first trading day. 4
Risk to monitor: Reuters reported that investors will be watching FOIL's reliance on a few large customers. That matters because a lost customer, weaker battery demand or delayed expansion can hit a concentrated supplier harder than a diversified manufacturer. The practical checkpoints are the final price, the August 12 listing, and the company's first post-IPO filing showing whether customer concentration or growth has changed. 5
Minimum buy-in and broker access: The $20-$22 range is an IPO price range, not a verified retail subscription minimum. No public allocation notice through Robinhood, Fidelity, Schwab, E*TRADE or Webull was verified in the sources reviewed. If FOIL appears in a brokerage app after listing, that would be ordinary market trading—not proof that the $20 IPO was available to that account.
Actionable now
No U.S. IPO allocation met all four checks for this edition: public offer terms, a live deadline, a minimum buy-in and a verified path through a mainstream retail broker. Public calendars confirm deals and listing events, but they do not establish that a retail investor can subscribe. 67
| Ticker | Price range | Minimum buy-in | Deadline | Verified brokers | Status |
|---|---|---|---|---|---|
| None verified | — | Not disclosed | No public allocation window found | None publicly verified | Watch only |
FOIL is a listing watch, not an actionable subscription.
Market pulse
- The biotech window is still attracting larger-than-planned deals. BlossomHill raised $150 million after initially targeting about $111.7 million, while Latigo raised $345.6 million after initially targeting $247.2 million. Fierce Biotech described both offerings as oversubscribed. Those are demand signals, but they do not mean every new IPO will trade well. 8
- The early results are selective, not uniformly hot. Renaissance's current priced-IPO table shows Braveheart Bio at +66.7% from its $18 IPO price, versus +1.4% for Latigo and 0.0% for BlossomHill. Use that spread as a reminder that a strong deal pipeline is not the same thing as a reliable first-day trade. 9
- FOIL has the week's clearest non-biotech demand test. Its $87 million of indicated institutional interest is larger than the $75 million midpoint deal, but the offer is still small relative to its roughly $1.6 billion expected market value. The final price will tell you more than the headline indication. 4
HK desk
No Hong Kong public subscription is open or closing by August 12 in the current public timetable. ET Net's August 10 IPO page shows no related information under active listing IPOs. The latest completed offer, NASN TECH, listed on August 7 at HK$10.42 with a 100-share board lot; its application window is over, so this is a post-listing result rather than an action today. 1011
On the radar: August 10-24
| Deal | Expected pricing/listing | Terms | Why watch |
|---|---|---|---|
| Londian Wason New Energy Tech (FOIL) | Expected NYSE listing Aug. 12 | 3.57M ADSs at $20-$22; about $75M at midpoint | Battery-materials exposure, named global customers and indicated institutional interest above the midpoint deal. 34 |
The current public calendars reviewed do not provide another dated traditional U.S. company IPO through August 24 with enough verified terms to add here. That keeps the watchlist short rather than filling it with undated filings or ETF and warrant events. 612
Market information only, not investment advice. IPO terms, dates and access can change before a final prospectus, pricing or listing.
References
- 1NYSE holidays and trading hours
nyse.com
- 2Londian Wason IPO profile
renaissancecapital.com
- 3Londian Wason IPO calendar entry
ipox.com
- 4US IPO week-ahead report
renaissancecapital.com
- 5Reuters report on Londian Wason's IPO
investing.com
- 6Renaissance Capital IPO calendar
renaissancecapital.com
- 7NYSE IPO filings
nyse.com
- 8Fierce Biotech on BlossomHill and Latigo
fiercebiotech.com
- 9Renaissance Capital recently priced IPOs
renaissancecapital.com
- 10ET Net IPO calendar
etnet.com.hk
- 11ET Net August 10 new listings memorandum
etnet.com.hk
- 12Yahoo Finance IPO calendar
finance.yahoo.com
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.